AAAAAA
Results: 26-50/139
Authors:
SEMINOMORA C
DALAKAS MC
Citation: C. Seminomora et Mc. Dalakas, DEPOSITION OF BETA-AMYLOID IN THE INTRAMUSCULAR NERVES OF PATIENTS WITH INCLUSION-BODY MYOSITIS (IBM), Neurology, 48(3), 1997, pp. 2104-2104
Authors:
LUCIANO CA
FUJII M
KOFFMAN B
DALAKAS MC
Citation: Ca. Luciano et al., HISTOLOGIC CORRELATES OF FIBRILLATION POTENTIALS IN INCLUSION-BODY MYOSITIS, Neurology, 48(3), 1997, pp. 2105-2105
Authors:
AMEMIYA K
DALAKAS MC
Citation: K. Amemiya et Mc. Dalakas, CYTOKINE MESSENGER-RNA EXPRESSION IN THE MUSCLE OF PATIENTS WITH INCLUSION-BODY MYOSITIS (IBM) BEFORE AND AFTER TREATMENT WITH STEROIDS ANDINTRAVENOUS IMMUNOGLOBULIN (IVIG), Neurology, 48(3), 1997, pp. 2107-2107
Authors:
KOFFMAN B
AMEMIYA K
LEONMONZON M
DALAKAS MC
Citation: B. Koffman et al., DEXAMETHASONE (DEX) INDUCES TRANSCRIPTION OF GLUTAMINE-SYNTHETASE (GS) IN HUMAN MUSCLE IN-VITRO - A POSSIBLE EXPLANATION OF STEROID-INDUCEDMUSCLE ATROPHY (STEROID MYOPATHY), Neurology, 48(3), 1997, pp. 5117-5117
Authors:
KARASOY H
SIVAKUMAR K
DALAKAS MC
Citation: H. Karasoy et al., UNUSUAL EXPRESSION OF LAMININ B1 IN 3 PATIENTS WITH ADULT-ONSET, LIMB-GIRDLE MUSCULAR-DYSTROPHY (LGMD), Neurology, 48(3), 1997, pp. 21006-21006
Authors:
DALAKAS MC
SONIES B
KOFFMAN B
SPECTOR S
SIVAKUMAR K
CUPLER E
LOPEZDEVINE J
Citation: Mc. Dalakas et al., HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN (IVIG) COMBINED WITH PREDNISONE IN THE TREATMENT OF PATIENTS WITH INCLUSION-BODY MYOSITIS (IBM) - A DOUBLE-BLIND, RANDOMIZED CONTROLLED TRIAL, Neurology, 48(3), 1997, pp. 41005-41005
Authors:
FUJII M
KOFFMAN B
SIVAKUMAR K
DALAKAS MC
Citation: M. Fujii et al., HISTOLOGIC CHARACTERISTICS IN REPEATED MUSCLE BIOPSIES OF PATIENTS WITH INCLUSION-BODY MYOSITIS (IBM) TREATED IN A CONTROL TRIAL WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN (IVIG) AND PREDNISONE, Neurology, 48(3), 1997, pp. 41006-41006
Authors:
DALAKAS MC
SONIES B
DAMBROSIA J
SEKUL E
CUPLER E
SIVAKUMAR K
Citation: Mc. Dalakas et al., TREATMENT OF INCLUSION-BODY MYOSITIS WITH IVIG - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Neurology, 48(3), 1997, pp. 712-716
Authors:
LUCIANO CA
DALAKAS MC
Citation: Ca. Luciano et Mc. Dalakas, INCLUSION-BODY MYOSITIS - NO EVIDENCE FOR A NEUROGENIC COMPONENT, Neurology, 48(1), 1997, pp. 29-33
Authors:
SEMINOMORA C
LEONMONZON M
DALAKAS MC
Citation: C. Seminomora et al., MITOCHONDRIAL AND CELLULAR TOXICITY INDUCED BY FIALURIDINE IN HUMAN MUSCLE IN-VITRO, Laboratory investigation, 76(4), 1997, pp. 487-495
Authors:
CASTELLI JC
HASSEL BA
WOOD KA
LI XL
AMEMIYA K
DALAKAS MC
TORRENCE PF
YOULE RJ
Citation: Jc. Castelli et al., A STUDY OF THE INTERFERON ANTIVIRAL MECHANISM - APOPTOSIS ACTIVATION BY THE 2-5A SYSTEM, The Journal of experimental medicine, 186(6), 1997, pp. 967-972
Authors:
SIVAKUMAR K
SEMINOMORA C
DALAKAS MC
Citation: K. Sivakumar et al., AN INFLAMMATORY, FAMILIAL, INCLUSION-BODY MYOSITIS WITH AUTOIMMUNE FEATURES AND A PHENOTYPE IDENTICAL TO SPORADIC INCLUSION-BODY MYOSITIS -STUDIES IN 3 FAMILIES, Brain, 120, 1997, pp. 653-661
Authors:
DALAKAS MC
Citation: Mc. Dalakas, MENINGITIS AND SKIN REACTION AFTER INTRAVENOUS IMMUNE GLOBULIN THERAPY - RESPONSE, Annals of internal medicine, 127(12), 1997, pp. 1130-1130
Authors:
DALAKAS MC
Citation: Mc. Dalakas, INTRAVENOUS IMMUNE GLOBULIN THERAPY FOR NEUROLOGIC DISEASES, Annals of internal medicine, 126(9), 1997, pp. 721-730
Authors:
DALAKAS MC
SIVAKUMAR K
Citation: Mc. Dalakas et K. Sivakumar, THE IMMUNOPATHOLOGIC AND INFLAMMATORY DIFFERENCES BETWEEN DERMATOMYOSITIS, POLYMYOSITIS AND SPORADIC INCLUSION-BODY MYOSITIS, Current opinion in neurology, 9(3), 1996, pp. 235-239
Authors:
POETTER K
JIANG H
HASSANZADEH S
MASTER SR
CHANG A
DALAKAS MC
RAYMENT I
SELLERS JR
FANANAPAZIR L
EPSTEIN ND
Citation: K. Poetter et al., MUTATIONS IN EITHER THE ESSENTIAL OR REGULATORY LIGHT-CHAINS OF MYOSIN ARE ASSOCIATED WITH A RARE MYOPATHY IN HUMAN HEART AND SKELETAL-MUSCLE, Nature genetics, 13(1), 1996, pp. 63-69
Authors:
DALAKAS MC
CUPLER EJ
Citation: Mc. Dalakas et Ej. Cupler, NEUROPATHIES IN HIV-INFECTION, Bailliere's clinical neurology, 5(1), 1996, pp. 199-218
Authors:
DALAKAS MC
QUARLES RH
FARRER RG
DAMBROSIA J
SOUEIDAN S
STEIN DP
CUPLER E
SEKUL EA
OTERO C
Citation: Mc. Dalakas et al., A CONTROLLED-STUDY OF INTRAVENOUS IMMUNOGLOBULIN IN DEMYELINATING NEUROPATHY WITH IGM GAMMOPATHY, Annals of neurology, 40(5), 1996, pp. 792-795
Authors:
CERVENAKOVA L
SIVAKUMAR K
NAGLE J
DALAKAS MC
GOLDFARB LG
Citation: L. Cervenakova et al., IS HEREDITARY INCLUSION-BODY MYOPATHY A FAMILIAL PRION DISEASE, Annals of neurology, 40(1), 1996, pp. 128-128
Authors:
DALAKAS MC
QUARLES RH
Citation: Mc. Dalakas et Rh. Quarles, AUTOIMMUNE ATAXIC NEUROPATHIES (SENSORY GANGLIONOPATHIES) - ARE GLYCOLIPIDS THE RESPONSIBLE AUTOANTIGENS, Annals of neurology, 39(4), 1996, pp. 419-422
Authors:
BASTA M
ILLA I
DALAKAS MC
Citation: M. Basta et al., INCREASED IN-VITRO UPTAKE OF THE COMPLEMENT C3B IN THE SERUM OF PATIENTS WITH GUILLAIN-BARRE-SYNDROME, MYASTHENIA-GRAVIS AND DERMATOMYOSITIS, Journal of neuroimmunology, 71(1-2), 1996, pp. 227-229
Authors:
FARRER RG
DALAKAS MC
QUARLES RH
Citation: Rg. Farrer et al., MULTIPLE ANTIBODIES TO NERVE GLYCOCONJUGATES IN A PATIENT WITH NEUROPATHY AND MONOCLONAL IGA GAMMOPATHY, Journal of neuroimmunology, 66(1-2), 1996, pp. 71-76
Authors:
CUPLER EJ
OTERO C
HENCH K
LUCIANO C
DALAKAS MC
Citation: Ej. Cupler et al., ACETYLCHOLINE-RECEPTOR ANTIBODIES AS A MARKER OF TREATABLE FATIGUE INHIV-1-INFECTED INDIVIDUALS, Muscle & nerve, 19(9), 1996, pp. 1186-1188
Authors:
LUCIANO CA
SIVAKUMAR K
SPECTOR SA
DALAKAS MC
Citation: Ca. Luciano et al., ELECTROPHYSIOLOGIC AND HISTOLOGIC-STUDIES IN CLINICALLY UNAFFECTED MUSCLES OF PATIENTS WITH PRIOR PARALYTIC POLIOMYELITIS, Muscle & nerve, 19(11), 1996, pp. 1413-1420
Authors:
SPECTOR SA
GORDON PL
FEUERSTEIN IM
SIVAKUMAR K
HURLEY BF
DALAKAS MC
Citation: Sa. Spector et al., STRENGTH GAINS WITHOUT MUSCLE INJURY AFTER STRENGTH TRAINING IN PATIENTS WITH POSTPOLIO MUSCULAR-ATROPHY, Muscle & nerve, 19(10), 1996, pp. 1282-1290